Houlihan Financial Resource Group’s Voyager Therapeutics VYGR Stock Holding History

Houlihan Financial Resource Group’s Portfolio VYGR Stock Details VYGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$3K	Buy	+300	New	+$3.52K	﹤0.01%	308

Other funds holding VYGR

TGI

TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Houlihan Financial Resource Group's VYGR Position: Q3 2020 in Review

Houlihan Financial Resource Group opened a new position in Voyager Therapeutics (VYGR) in Q3 2020: 300 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #308 among its holdings.

110 funds tracked by Wall St. Rank hold VYGR as of Q3 2020.

Houlihan Financial Resource Group held 300 shares of Voyager Therapeutics worth $3K as of Q3 2020.
Voyager Therapeutics was a new Houlihan Financial Resource Group position in Q3 2020.
Voyager Therapeutics made up ﹤0.01% of Houlihan Financial Resource Group's portfolio in Q3 2020, its #308 holding.
110 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2020.

Based on Houlihan Financial Resource Group's 13F filing for Q3 2020, filed 13 Nov 2020.